Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-12

Clinical Trial Update: EpCAM-Targeted Surface-Enhanced Raman Spectroscopy Nanotags for Rapid Evaluation of Surgical Margins and Sentinel Lymph Node Metastasis Status in Breast Cancers

View source ↗

Summary

This clinical trial update describes EpCAM-targeted Surface-Enhanced Raman Spectroscopy nanotags for rapid evaluation of surgical margins and sentinel lymph nod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EpCAM-targeted Surface-Enhanced Raman Spectroscopy (SERS) Nanotags

Snippet

Sponsor: Yunnan Cancer Hospital | Conditions: Sentinel Lymph Node, Breast Cancers | Status: NOT_YET_RECRUITING